{"a":[{"_":"Merck, AZ lawsuits against Medicare price negotiations swatted down","$":{"href":"/pharma/merck-az-lawsuits-against-medicare-price-negotiations-are-swatted-away","hreflang":"en"}}]}

RegulatoryrejectedNegative

AI Analysis

Summary

Courts in Maryland and Washington, D.C., have rejected separate lawsuits filed by Merck and AstraZeneca challenging the Centers for Medicare & Medicaid Services' drug price negotiation program. The legal setback represents a significant development in the ongoing disputes over Medicare drug price negotiation authority.

Outcome Details

Courts in Maryland and Washington, D.C., rejected separate lawsuits by Merck and AstraZeneca against the CMS drug price negotiation program

Importance:6/10

Sentiment:

-0.70

litigationMedicareprice negotiationsregulatorylegal

Related Companies

$MRK $AZN

Read the original article

Published by FiercePharma on August 24, 2026 3:20 PM

Read Original